文献速递产科母胎医学

妊娠期重型和危重型COVID-19住院患者的临床病程:美国队列研究

Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study.
PubMed 文献 · Am J Obstet Gynecol MFM · 2020-05-08

该美国多中心队列研究纳入64例住院的重型或危重型COVID-19孕妇,其中重型44例(69%)、危重型20例(31%)。危重型患者急性呼吸窘迫综合征发生率达70%,但无孕产妇死亡、心肌病或围产期死亡。住院期间50%患者分娩,危重型患者早产和剖宫产率较高。

要点

  • 住院的重型/危重型COVID-19孕妇中,危重型占31%,急性呼吸窘迫综合征发生率高达70%。
  • 危重型患者住院时间更长(10.5天 vs 6天,P=.01),且85%在住院期间分娩。
  • 本队列无孕产妇死亡、心肌病、死产、新生儿死亡或垂直传播病例。

核心结论

  • 妊娠期重型或危重型COVID-19患者通常在症状出现约7天后入院,住院时间中位数为6天(重型6天 vs 危重型10.5天,P=.01)。
  • 危重型患者急性呼吸窘迫综合征发生率高(70%),但本队列无孕产妇死亡、心肌病或围产期死亡。
  • 50%的患者在住院期间分娩,危重型患者早产(75%)和剖宫产(94%)比例较高。

研究设计与样本

  • 美国12家机构于2020年3月5日至4月20日开展的多中心队列研究。
  • 纳入64例实验室确诊SARS-CoV-2感染且为重型或危重型的住院孕妇,排除疑似但检测阴性者。
  • 重型定义依据已发表标准:患者报告呼吸困难、呼吸频率>30次/分、室内空气血氧饱和度≤93%、动脉血氧分压/吸入氧浓度<300 mm Hg,或24-48小时内胸部影像显示肺浸润>50%。
  • 危重型定义为呼吸衰竭、感染性休克或多器官功能障碍或衰竭。
  • 主要结局为入院至出院的中位时间,次要结局包括补充氧疗、插管、心肌病、心脏骤停、死亡及分娩时机。

主要发现

  • 64例中重型44例(69%),危重型20例(31%)。
  • 既往合并症:25%有肺部疾病,17%有心脏病,平均体重指数34 kg/m2。
  • 症状出现时平均孕周29±6周,入院时平均孕周30±6周,入院时为症状出现后中位第7天。
  • 治疗:81%使用羟氯喹;重型中7%、危重型中65%使用瑞德西韦;所有危重型患者均接受预防性或治疗性抗凝。
  • 住院时间中位数6天(重型6天,危重型10.5天;P=.01)。

临床怎么用

  • 对妊娠期重型或危重型COVID-19患者应警惕危重型的高急性呼吸窘迫综合征风险,并加强呼吸监测与支持。
  • 危重型患者住院期间分娩率高且多为早产和剖宫产,需产科与重症团队协同管理。
  • 本队列无垂直传播和围产期死亡,可为咨询提供参考,但需结合更大样本验证。

局限性

  • 样本量较小(64例),可能限制结果的普遍性。
  • 为观察性队列研究,未设对照组,无法推断治疗措施的因果效应。
  • 研究期间部分治疗(如羟氯喹、瑞德西韦)的使用可能受当时指南和药物可及性影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The coronavirus disease 2019 pandemic has had an impact on healthcare systems around the world with 3 million people contracting the disease and 208,000 cases resulting in death as of this writing. Information regarding coronavirus infection in pregnancy is still limited. OBJECTIVE: This study aimed to describe the clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnant women with positive laboratory testing for severe acute respiratory syndrome coronavirus 2. STUDY DESIGN: This is a cohort study of pregnant women with severe or critical coronavirus disease 2019 hospitalized at 12 US institutions between March 5, 2020, and April 20, 2020. Severe disease was defined according to published criteria as patient-reported dyspnea, respiratory rate >30 per minute, blood oxygen saturation ≤93% on room air, ratio of partial pressure of arterial oxygen to the fraction of inspired oxygen <300 mm Hg, or lung infiltrates >50% within 24-48 hours on chest imaging. Critical disease was defined as respiratory failure, septic shock, or multiple organ dysfunction or failure. Women were excluded from the study if they had presumed coronavirus disease 2019, but laboratory testing was negative. The primary outcome was median duration from hospital admission to discharge. Secondary outcomes included need for supplemental oxygen, intubation, cardiomyopathy, cardiac arrest, death, and timing of delivery. The clinical courses are described by the median disease day on which these outcomes occurred after the onset of symptoms. Treatment and neonatal outcomes are also reported. RESULTS: Of 64 hospitalized pregnant women with coronavirus disease 2019, 44 (69%) had severe disease, and 20 (31%) had critical disease. The following preexisting comorbidities were observed: 25% had a pulmonary condition, 17% had cardiac disease, and the mean body mass index was 34 kg/m2. Gestational age was at a mean of 29±6 weeks at symptom onset and a mean of 30±6 weeks at hospital admission, with a median disease day 7 since first symptoms. Most women (81%) were treated with hydroxychloroquine; 7% of women with severe disease and 65% of women with critical disease received remdesivir. All women with critical disease received either prophylactic or therapeutic anticoagulation during their admission. The median duration of hospital stay was 6 days (6 days [severe group] and 10.5 days [critical group]; P=.01). Intubation was usually performed around day 9 on patients who required it, and peak respiratory support for women with severe disease was performed on day 8. In women with critical disease, prone positioning was required in 20% of cases, the rate of acute respiratory distress syndrome was 70%, and reintubation was necessary in 20%. There was 1 case of maternal cardiac arrest, but there were no cases of cardiomyopathy or maternal death. Thirty-two of 64 (50%) women with coronavirus disease 2019 in this cohort delivered during their hospitalization (34% [severe group] and 85% [critical group]). Furthermore, 15 of 17 (88%) pregnant women with critical coronavirus disease 2019 delivered preterm during their disease course, with 16 of 17 (94%) pregnant women giving birth through cesarean delivery; overall, 15 of 20 (75%) women with critical disease delivered preterm. There were no stillbirths or neonatal deaths or cases of vertical transmission. CONCLUSION: In pregnant women with severe or critical coronavirus disease 2019, admission into the hospital typically occurred about 7 days after symptom onset, and the duration of hospitalization was 6 days (6 [severe group] vs 12 [critical group]). Women with critical disease had a high rate of acute respiratory distress syndrome, and there was 1 case of cardiac arrest, but there were no cases of cardiomyopathy or maternal mortality. Hospitalization of pregnant women with severe or critical coronavirus disease 2019 resulted in delivery during the clinical course of the disease in 50% of this cohort, usually in the third trimester. There were no perinatal deaths in this cohort.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Pierce-Williams RAM, Burd J, Felder L, et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study. Am J Obstet Gynecol MFM. 2020. PMID: 32391519. doi:10.1016/j.ajogmf.2020.100134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。